The journey to precision medicine

View this infographic to see the nine steps you'll need to take on the path to making personalized medicine widely available.

Precision medicine investment playbook

Read this study to learn 10 lessons for success in the era of personalized medicine, including business planning considerations, strategies to help physicians put personalized medicine into practice, and guidance for managing molecular data.

The precision medicine business plan template

As you consider investment in personalized medicine, you should develop a comprehensive business plan that provides an in-depth analysis of the proposed investment and plan for implementation. For example, cancer program leaders must evaluate how personalized medicine aligns with their larger institutional goals, how to measure the market for these tests, how to integrate testing into the care pathway, and how to look at the financial implications of investment. You can use this customizable template to develop your own business plan for personalized medicine.

Innovations in medical oncology: Evaluate the business case for precision medicine

Learn about the four key elements of building a successful precision medicine business case and how one health system created a comprehensive strategy for developing a precision medicine program.

CAR T-cell therapy demand estimator

Use this tool to calculate current and future demand for CAR T-cell therapy in your market based on market-level estimates of cancer incidence.

Precision medicine volumes calculator and financial pro forma

This tool, a companion to the Personalized Medicine Business Plan Template, lets you calculate potential demand for tumor biomarker testing and evaluate the costs and revenues of testing. Using organization-specific data and adjustable assumptions, you can project future volumes and compare the financial implications of performing personalized medicine tests in house or through an external partner.

Innovations in medical oncology: Best practices

Learn about how cancer programs have used four key practices to implement their precision medicine programs, including providing support for oncologists, developing patient-centered standards, elevating the role of clinical trials, and harnessing the power of data.

How oncology programs are providing access to precision medicine

The field of precision medicine is rapidly evolving, and cancer programs struggle to stay on top of advances, make informed investments, and help providers put precision medicine into practice. Read on to see how cancer programs are offering molecular testing and immunotherapy to their patients.

Precision medicine can be a game changer—learn how IT plays a critical role

Precision medicine has the potential to dramatically transform health care delivery by utilizing massive new data streams (e.g., genomics) across patient cohorts and partner ecosystems to help clinicians better understand disease and provide more precise and proactive prevention, diagnoses, and treatments for each patient. Here's how you can leverage IT to help.

How Intermountain overcame 2 key barriers to precision medicine

Read this article to learn how Intermountain Healthcare tackled two key challenges and is advancing the field to offer more patients personalized cancer treatment by analyzing their genomic makeup.

Lab partner vetting worksheet

Providers that outsource molecular diagnostic tests should use this worksheet as a guide to select lab partners that meet their organizations’ needs.

What providers and health plans still find challenging about lab services

Discover the biggest lab-related challenges for providers and health plans to identify opportunities for partnership and cross-stakeholder support.

Advance your organization's biomarker testing program

Use this diagnostic tool to identify opportunities to improve your organization’s biomarker testing process.

Understanding the biomarker testing patient journey

Use this infographic to follow the patient journey, understand the steps in the biomarker testing process, identify where challenges can arise, and evaluate how difficult it will be to overcome common barriers to biomarker testing success.

Biomarker testing program resource grid

Use this resource grid to support your biomarker program growth and development.

Clinical technology vendors can enable data integration

View these two slides from the 2021 Oncology State of the Union to see how Rush University Medical Center partnered with Tempus and Epic to integrate tumor genomic data into their EHR.

How are your peers managing immunotherapies? Here's what you need to know.

Read what your peers said are their biggest challenges and priorities when it comes to checkpoint inhibitors and CAR T-cell therapy.

Immunotherapy: What patients are hearing—and how to guide their expectations

Learn two common misconceptions about immunotherapy treatments you can start addressing with patients.

How centers are building out capabilities and struggling to get reimbursed

Learn how one leading cancer center has reorganized its services to improve care for immunotherapy patients and how barriers to CAR T reimbursement are raising concerns about access.

Medicare is expanding CAR T-cell therapy coverage nationwide. (But some providers aren't happy.)

Read our take on CMS's finalized national coverage determination for CAR T-cell therapies.

Personalized medicine glossary

Get a list of commonly used personalized medicine terms and their definitions.

Oncology clinical technology compendium

Learn about the latest technologies for surgical, interventional, medical, and radiation oncology as well as cancer screening and diagnosis.

Innovations in medical oncology: Innovations in brief

Read this briefing to receive an overview of eight precision medicine innovations.

Innovations that may change the cancer treatment paradigm

View these slides on seven recent innovations with the potential to change the cancer treatment paradigm and implications for key oncology stakeholders.

Biomarker testing in oncology

Learn how understanding a cancer patient’s genetic profile can help guide appropriate treatment selection.

Understanding the importance of oncology biomarker testing

Discover three key recommendations on the providers’ role in advancing biomarker testing.

Your top resources to understand pharmacogenomics

This resource library will help you educate yourself and your organization about pharmacogenomics and gain buy-in to start or grow a health system pharmacogenomics program.

Cheat sheet: Pharmacogenomics

Use this cheat sheet to gain an understanding pharmacogenomics and the potential applications.

Can CAR T-cell therapy truly ‘cure’ cancer?

Learn about the latest long-term data published about CAR T-cell therapy and our four biggest questions on the future of CAR T.

‘This is a big deal’: A new drug targets long-evasive mutation in lung cancers

Read our four immediate takeaways for cancer administrators and providers following positive clinical trial results of a new targeted therapy for lung cancer.

Liquid biopsies for early cancer detection and disease monitoring

Learn about the promise and outlook of liquid biopsies for early cancer detection and disease monitoring.

Non-invasive cancer diagnostics

Use this cheat sheet to gain an understanding of the potential applications of non-invasive diagnostic tests.